Study record

Exercise-Induced Muscle-Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging

Tero-Vescan A, Degens H, Matsakas A et al. · Pharmaceuticals (Basel) · 2025

ReviewSeveralEvidence tier R

What this study reported

Reviewed reported mechanisms of exercise-induced crosstalk between skeletal muscle and adipose tissue, including IL-6, irisin, leptin and adiponectin, and AMPK, PGC-1α, SIRT1 and PI3K/Akt/mTOR signalling. Described MOTS-c among emerging exercise mimetics discussed in relation to muscle mass, browning of white adipose tissue and systemic metabolic function, and proposed a stratified framework for age-related comorbidities.

Limitations

Narrative review with no stated search strategy or appraisal of the cited studies; MOTS-c is mentioned only briefly among many mediators, and the proposed treatment algorithm is not derived from pooled or graded evidence.

Study record

Annotated fields for this study
Study modelReview
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
SpeciesNot reported
System studiedNarrative review of exercise-induced muscle-adipose crosstalk and candidate exercise mimetics, including MOTS-c
PopulationNot reported
DesignNarrative review
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)Not reported
Endpoints measuredmyokine and adipokine signalling; mitochondrial biogenesis; fatty acid oxidation; muscle hypertrophy signalling; metabolic flexibility
Pathways measuredAMPK signalling · SIRT1 / PGC-1α / biogenesis · AKT / mTOR / FOXO · Thermogenesis / brown fat · Lipid metabolism · Inflammation
Research areasExercise · Metabolic · Aging · Skeletal muscle
Evidence tierR — Review (context, not evidence)
Publication typesJournal Article, Review

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Peripheral
Model applicability
n/a
Sample size
n/a
Controls
n/a
Outcome validity
n/a
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.